Related Experiment Video
Updated: Jan 24, 2026

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
Published on: March 11, 2016
MD2 blockade prevents oxLDL-induced renal epithelial cell injury and protects against high-fat-diet-induced kidney
Sujing Xu1, Wu Luo1, Xiaohong Xu1
1Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Abstract:
There is a strong epidemiological link between obesity, a growing worldwide concern, and kidney disease. Emerging evidence indicates that the pathogenic basis of obesity-related kidney disease may be attributed to Toll-like receptor 4 (TLR4) of the innate immune system. We hypothesized that renal epithelial cell injury in response to oxidized low-density lipoprotein (oxLDL) requires myeloid differentiation factor 2 (MD2), a co-receptor of TLR4. Moreover, we also hypothesized that renal dysfunction is MD2-dependent in the high-fat diet (HFD) mouse model. Results indicated that the MD2 selective inhibitor (L6H21) abrogated the oxLDL-induced formation of MD2-TLR4 dimerization in the renal proximal tubular epithelial cell line NRK-52E. Further, MD2 blockade in NRK-52E cells using siRNA target sequences or L6H21 prevented oxLDL-induced cell injury as indicated by expression of profibrotic molecules, autophagic activity and apoptosis. Similarly, TLR4 knockdown in NRK-52E cells using siRNA target sequences prevented oxLDL-induced cell injury. In the HFD mouse model, MD2 knockout protected against development of kidney dysfunction and renal tissue injury, corroborating the observations observed in NRK-52E cells. Thus, the oxLDL-induced renal tubular epithelial cell profibrotic responses, autophagy and apoptosis were dependent on MD2, as were the renal dysfunction and tissue impairment in HFD mice. These are new findings indicating that the MD2-TLR4 immune signaling complex is a critical pathogenic factor in the development of kidney disease related to obesity or metabolic syndrome.
Insights
Obesity-related kidney disease involves the immune system. Myeloid differentiation factor 2 (MD2) and Toll-like receptor 4 (TLR4) mediate kidney injury from oxidized LDL and high-fat diets, suggesting MD2-TLR4 as a therapeutic target.
Area of Science:
- Immunology
- Nephrology
- Metabolic Syndrome
Background:
- Obesity is a global health issue strongly linked to kidney disease.
- The innate immune system, specifically Toll-like receptor 4 (TLR4), is implicated in obesity-related kidney disease pathogenesis.
- Oxidized low-density lipoprotein (oxLDL) is a potential mediator of kidney injury in metabolic conditions.
Purpose of the Study:
- To investigate the role of myeloid differentiation factor 2 (MD2), a TLR4 co-receptor, in renal epithelial cell injury induced by oxLDL.
- To determine if renal dysfunction in a high-fat diet (HFD) mouse model is dependent on MD2.
- To explore the MD2-TLR4 immune signaling complex as a pathogenic factor in obesity-associated kidney disease.
Main Methods:
- Utilized a selective MD2 inhibitor (L6H21) and siRNA to block MD2 and TLR4 in NRK-52E renal proximal tubular epithelial cells.
- Assessed oxLDL-induced cell injury by measuring profibrotic molecules, autophagy, and apoptosis.
- Employed a high-fat diet (HFD) mouse model with MD2 knockout to evaluate in vivo renal dysfunction and tissue injury.
Main Results:
- MD2 selective inhibitor (L6H21) and siRNA targeting MD2 or TLR4 abrogated oxLDL-induced MD2-TLR4 dimerization and subsequent cell injury in NRK-52E cells.
- MD2 blockade prevented oxLDL-induced profibrotic responses, autophagy, and apoptosis.
- MD2 knockout in HFD mice significantly protected against kidney dysfunction and renal tissue damage.
Conclusions:
- MD2 is essential for oxLDL-induced renal tubular epithelial cell injury, including profibrotic responses, autophagy, and apoptosis.
- MD2-dependent pathways mediate renal dysfunction and tissue impairment in a HFD-induced obesity mouse model.
- The MD2-TLR4 immune signaling complex represents a critical pathogenic factor in obesity- and metabolic syndrome-related kidney disease, offering a potential therapeutic target.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Kidney Structure
Neuromuscular Junction And Blockade
Acute Kidney Injury I: Introduction

